Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics

Medicine
Samer NassifFouad I Boulos

Abstract

CD30 is a member of the tumor necrosis factor family of cell surface receptors normally expressed in lymphocytes, as well as some lymphomas, but has been described in other malignancies. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that belongs to the insulin receptor superfamily, and is normally expressed in neural cells, but has been detected in several malignancies. There is conflicting data in the literature that describes the expression of these receptors in breast cancer, and the aim of this study is to test the expression of CD30 and ALK in a cohort of Middle Eastern patients with breast carcinoma.Cases of invasive breast cancer from the archives of AUBMC were reviewed over a period of 9 years, and the blocks that were used for immunohistochemical staining for ER, PR, Her-2/neu were selected. Immunohistochemical staining for CD30 (JCM182) and ALK (5A4 and D5F3) was performed.Two hundred eighty-four cases were identified (2 cases were male), with a mean age of 55 ± 12. CD30 and ALK expression was not seen in any of the cases.Our cohort showed complete negativity to both CD30 and ALK, adding to the conflicting data available in the literature, and more studies are needed to reliably identify a trend of ex...Continue Reading

References

Mar 23, 2000·The Journal of Pathology·H DürkopH Stein
May 4, 2000·The American Journal of Pathology·L LamantB Mariamé
Dec 4, 2004·The American Journal of Surgical Pathology·Toyonori TsuzukiJonathan I Epstein
May 11, 2007·Biochemical and Biophysical Research Communications·Pablo Perez-PineraT F Deuel
Apr 17, 2008·British Journal of Cancer·Y FukuyoshiM Mori
Apr 28, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anuradha GopalanSatish K Tickoo
Sep 10, 2009·Molecular Cancer Research : MCR·Eva LinZora Modrusan
Sep 18, 2009·Advances in Experimental Medicine and Biology·Ezogelin OflazogluHanspeter Gerber
Feb 1, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Eunhee S YiPing Yang
Oct 12, 2011·Current Opinion in Oncology·Anas Younes
Nov 15, 2011·Breast Cancer Research and Treatment·L C CollinsA H Partridge
Mar 24, 2012·Critical Reviews in Oncology/hematology·Andrés J M FerreriKerry J Savage
Jun 21, 2012·British Journal of Cancer·D H MorrisonV R Sarode
Nov 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jong-Mu SunKeunchil Park
Jan 12, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Akihiko YoshidaHitoshi Tsuda
Jan 18, 2013·Targeted Oncology·Francesca CasaluceCesare Gridelli
Oct 9, 2013·SpringerPlus·Fredika M RobertsonMassimo Cristofanilli
Sep 19, 2015·Breast Cancer Research : BCR·Abdul K SirajKhawla S Al-Kuraya
Dec 28, 2016·PLoS Medicine·Celine LefebvreFabrice André
Feb 12, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A J van der WekkenH J M Groen

❮ Previous
Next ❯

Citations

May 29, 2020·Breast Cancer Research and Treatment·Zeina HassanEman Sbaity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.